股票 › LTGO
拉蒂戈生物治疗 LTGO
美股市值排名 #3342
$12.60 −$0.41 (-3.15%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $12.30 -2.38%
开盘$13.18
昨收$13.01
当日区间$12.11 – $15.95
成交量556.1K
市值$835.37M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例69.0%+68.97 个百分点，较上季度
持仓机构数14+14 ，较上季度
内部人近期交易6次买入 / 0次卖出净买入
空头持仓比例1.19% 占流通股回补天数 2.5 · 截至 15 Oct 2026
卖空成交量占比18.2%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$5,179（9个净流入日，11个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有59.5%的流通股。
最大股东
按投资者类型
过去5次双周报告中（14 Aug 2026至15 Oct 2026），空头持仓占流通股比例已从0.22%升至1.19%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Charles Schwab Investment Management | Mutual Fund | 2026/Q3 | +110,534 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +985,327 | 1.5% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +216,879 | 0.3% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +9,108 | 0.0% |
| FMR | Mutual Fund | 2026/Q3 | +1,018,728 | 1.5% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +67,364 | 0.1% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,074 | 0.0% |
| Vanguard Global Advisers, LLC | Mutual Fund | 2026/Q3 | +664 | 0.0% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +4,446,656 | 6.7% |
| Leonard Blavatnik | Individual/Insider | 2026/Q3 | +3,185,177 | 4.8% |
| Westlake Village BioPartners | VC/PE Fund | 2026/Q3 | +13,199,669 | 19.9% |
| Foresite Capital Management, LLC | VC/PE Fund | 2026/Q3 | +9,181,328 | 13.8% |
| 5AM Venture Management, LLC | VC/PE Fund | 2026/Q3 | +7,325,962 | 11.0% |
| RA Capital Management, L.P. | VC/PE Fund | 2026/Q3 | +5,295,690 | 8.0% |
| Sanofi | Public Company | 2026/Q3 | +672,788 | 1.0% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 9 Aug 2026 | Sanofi | Derivative Exercise and Retained | +672,778 | – | 672,788 | |
| 9 Aug 2026 | 5AM Venture Management, LLC | Derivative Exercise and Retained | +7,325,962 | – | 7,325,962 | |
| 9 Aug 2026 | Foresite Capital Management, LLC | Open Market Acquisition | +140,000 | $18.00 | 9,181,328 | |
| 9 Aug 2026 | Foresite Capital Management, LLC | Derivative Exercise and Retained | +9,041,328 | – | 9,181,328 | |
| 9 Aug 2026 | Westlake Village BioPartners | Derivative Exercise and Retained | +12,695,305 | – | 13,199,669 | |
| 5 Aug 2026 | James Tananbaum | Independent Director | Initial Statement of Beneficial | +0 | – | 1,484,401 |
| 5 Aug 2026 | Sanofi | Initial Statement of Beneficial | +0 | – | 494,800 | |
| 5 Aug 2026 | Andrew Schwab | Initial Statement of Beneficial | +0 | – | 1,484,401 | |
| 5 Aug 2026 | Timothy Walbert | Independent Chairperson | Initial Statement of Beneficial | +0 | – | 329,819 |
| 5 Aug 2026 | Todd Smith | Independent Director | Other Derivative Acquisition | +105,542 | $18.00 | 105,542 |
| 5 Aug 2026 | Nima Farzan | Chief Executive Officer | Initial Statement of Beneficial | +0 | – | 2,787,966 |
| 5 Aug 2026 | Sara Bonstein | Independent Director | Initial Statement of Beneficial | +0 | – | 105,542 |
| 5 Aug 2026 | Westlake Village BioPartners | Initial Statement of Beneficial | +0 | – | 679,620 | |
| 5 Aug 2026 | Neha Krishnamohan | Chief Business Officer & CFO | Initial Statement of Beneficial | +0 | – | 686,026 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 785,880 | 1.2% | 2.5 |
| 30 Sep 2026 | 832,088 | 1.3% | 1.6 |
| 15 Sep 2026 | 449,962 | 0.7% | 2.1 |
| 31 Aug 2026 | 308,625 | 0.5% | 1.7 |
| 14 Aug 2026 | 134,468 | 0.2% | 1.0 |
暂无评论——快来第一个聊聊 LTGO。
登录后参与讨论。